Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II double-blind placebo-controlled trial of HSK21542 tablets for moderate to severe pruritus in peritoneal dialysis patients
CTR20240448Phase 2Active
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Start
- Mar 2024
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of hsk21542 in chronic pruritus (CP), sponsored by Haisco Pharmaceutical Group Co., Ltd.. Started Mar 2024; status: active.
02
Drugs
hsk21542
03
Conditions
chronic pruritus (CP)
Beyond the preview
Go deeper on CTR20240448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240448.